A Filipino pharmaceutical firm plans to build the country’s first vaccine plant to manufacture coronavirus disease 2019 (Covid-19) vaccine.
Glovax Biotech has informed the Department of Trade and Industry (DTI) and the Bureau of Investments of its desire to construct a vaccine plant in partnership with South Korea-based Eubiologics and LG Chem to produce EuCorVac-19 vaccine, which was developed by POP Biotechnologies.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.